Pharmacokinetics of Viloxazine ER (Viloxazine Extended-Release Capsules) in Breast Milk of Healthy Lactating Women
The Journal of Clinical Psychiatry · 05.08.2026 · 87 (3)
DOI: 10.4088/jcp.25m16169 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 05.08.2026. Verfasst von Ying Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Supernus Pharmaceuticals, Inc., Rockville, Maryland. Hauptthemen laut MEDLINE: Lactation, Milk, Human, Viloxazine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Supernus Pharmaceuticals, Inc., Rockville, Maryland.
- Corresponding Author: Zhao Wang, MD, Supernus Pharmaceuticals, Inc., 9715 Key West Ave, Rockville, MD 20850 (zwang@supernus.com).
Zitieren
APA
Cai, Y., Wang, Z., Alleyne, N., Earnest, J., Lin, M., & Upadhyaya, H. (2026). Pharmacokinetics of Viloxazine ER (Viloxazine Extended-Release Capsules) in Breast Milk of Healthy Lactating Women. The Journal of Clinical Psychiatry, 87(3). https://doi.org/10.4088/jcp.25m16169
Vancouver
Cai Y, Wang Z, Alleyne N, Earnest J, Lin M, Upadhyaya H. Pharmacokinetics of Viloxazine ER (Viloxazine Extended-Release Capsules) in Breast Milk of Healthy Lactating Women. The Journal of Clinical Psychiatry. 2026;87(3). doi:10.4088/jcp.25m16169
BibTeX
@article{Cai2026,
author = {Cai, Ying and Wang, Zhao and Alleyne, Nicole and Earnest, Jami and Lin, Mary and Upadhyaya, Himanshu},
title = {Pharmacokinetics of Viloxazine ER (Viloxazine Extended-Release Capsules) in Breast Milk of Healthy Lactating Women},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
volume = {87},
number = {3},
doi = {10.4088/jcp.25m16169}
}
EUVIMED